How much funding has Laekna Therapeutics raised?

Laekna Therapeutics has raised $168.0M in total funding, most recently a Series A round.

Who are Laekna Therapeutics's investors?

Laekna Therapeutics's investors include OrbiMed, Shenzhen Capital Group, GP Healthcare Capital, Infinity Capital.

When was Laekna Therapeutics founded?

Laekna Therapeutics was founded in 2016.

Where is Laekna Therapeutics headquartered?

Laekna Therapeutics is headquartered in Shanghai, China.

What industry is Laekna Therapeutics in?

Laekna Therapeutics operates in Biotech, Healthcare.

How many employees does Laekna Therapeutics have?

Laekna Therapeutics has 51-200 employees.

Laekna Therapeutics

Laekna

Shanghai, China · Founded 2016 · $168.0M raised

Biotech

Healthcare

Headquarters: Shanghai
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: laekna.com
Total Funding: $168.0M
Last Round: $18.5M Series AMay 2022
Rounds: 4

About

Laekna is a science-driven, clinical-stage biotechnology company committed to bringing novel therapeutics to patients with cancer, metabolic diseases, and liver fibrosis. Its pipeline spans AKT inhibitors, ActRIIA antibodies, and other internally discovered drug candidates across oncology, metabolic diseases, and liver fibrosis indications globally.

Summary

Laekna Therapeutics is a Biotech company based in Shanghai, China, founded in 2016. It has raised $168.0M in total across 4 rounds, most recently a $18.5M Series A round in May 2022. Investors include OrbiMed, Shenzhen Capital Group and GP Healthcare Capital.